• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MediciNova, Inc. - Common Stock (NQ:MNOV)

    1.470 +0.070 (+4.99%)
    Streaming Delayed Price Updated: 9:47 AM EST, Nov 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 42,420
    Open 1.470
    Bid (Size) 1.460 (2,000)
    Ask (Size) 1.470 (300)
    Prev. Close 1.400
    Today's Range 1.460 - 1.490
    52wk Range 1.130 - 2.550
    Shares Outstanding 49,046,246
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
    From MediciNova, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -31.0%
    -31.0%
    1 Month
    +17.1%
    +17.1%
    3 Month
    +7.3%
    +7.3%
    6 Month
    -1.3%
    -1.3%
    1 Year
    -5.8%
    -5.8%

    More News

    Read More
    MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’
    Via Stocktwits
    Unusual volume stocks in Monday's session
    Via Chartmill
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Which stocks are experiencing notable movement on Friday?
    Via Chartmill
    These stocks have an unusual volume in today's session
    Via Chartmill
    Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
    Via Benzinga
    MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova to Present at the LD Micro Main Event XIX Investor Conference
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Provides Shareholder Update on Key Developments
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
    From MediciNova, Inc.
    Via GlobeNewswire
    First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
    From MediciNova, Inc.
    Via GlobeNewswire
    This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
    Via Benzinga
    MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
    From MediciNova, Inc.
    Via GlobeNewswire
    MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver
    From MediciNova, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is MediciNova, Inc. - Common Stock publicly traded?
    Yes, MediciNova, Inc. - Common Stock is publicly traded.
    What exchange does MediciNova, Inc. - Common Stock trade on?
    MediciNova, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for MediciNova, Inc. - Common Stock?
    The ticker symbol for MediciNova, Inc. - Common Stock is MNOV on the Nasdaq Stock Market
    What is the current price of MediciNova, Inc. - Common Stock?
    The current price of MediciNova, Inc. - Common Stock is 1.470
    When was MediciNova, Inc. - Common Stock last traded?
    The last trade of MediciNova, Inc. - Common Stock was at 11/07/25 09:47 AM ET
    What is the market capitalization of MediciNova, Inc. - Common Stock?
    The market capitalization of MediciNova, Inc. - Common Stock is 72.09M
    How many shares of MediciNova, Inc. - Common Stock are outstanding?
    MediciNova, Inc. - Common Stock has 72M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.